Cytek Biosciences, Inc. (CTKB): Shareholders' Equity
$341.74M
As of 2025-12-31
$321.95M
As of 2026-06-30
-7.1%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $341.74M | -13.6% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $395.74M | +0.7% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $393.06M | -7.6% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $425.55M | +5.0% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $405.38M | n/m | 2024-03-13, Balance as of period end |
| 2020-12-31 | -$16.03M | n/a | 2023-03-01, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $341.74M | -13.6% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $5.35M | -98.9% |
| Quanterix Corp (QTRX) | 2025-12-31 | $295.73M | -10.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $13.73M | -78.3% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $796.33M | +12.1% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $143.70M | +25.4% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.21M | -55.9% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $306.11M | -9.0% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $44.42M | +25.6% |
Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗